ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,820.21
0.03%
Gold vs US Dollar
2,420.375
-0.25%
Brent Oil
82.525
-1.20%
Bitcoin
69,831.50
-2.26%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SpringWorks Therapeutics Inc (SWTX)

  7. SpringWorks Therapeutics Inc (SWTX) News

SpringWorks Therapeutics (SWTX)

SpringWorks Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SWTX
DateTimeSourceHeadlineSymbolCompany
17/05/202421:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SWTXSpringWorks Therapeutics Inc
08/05/202412:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
02/05/202411:30GlobeNewswire Inc.SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business UpdatesNASDAQ:SWTXSpringWorks Therapeutics Inc
24/04/202418:31GlobeNewswire Inc.SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:SWTXSpringWorks Therapeutics Inc
18/04/202412:00GlobeNewswire Inc.SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024NASDAQ:SWTXSpringWorks Therapeutics Inc
04/03/202411:30GlobeNewswire Inc.SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PNNASDAQ:SWTXSpringWorks Therapeutics Inc
01/03/202422:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
29/02/202413:30GlobeNewswire Inc.SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid TumorsNASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202413:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202413:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202412:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202411:51Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202411:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SWTXSpringWorks Therapeutics Inc
27/02/202411:30GlobeNewswire Inc.SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business UpdatesNASDAQ:SWTXSpringWorks Therapeutics Inc
22/02/202412:00GlobeNewswire Inc.SpringWorks Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:SWTXSpringWorks Therapeutics Inc
20/02/202423:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
16/02/202418:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
14/02/202413:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SWTXSpringWorks Therapeutics Inc
06/02/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
06/02/202402:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
02/02/202421:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
02/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SWTXSpringWorks Therapeutics Inc
31/01/202412:00GlobeNewswire Inc.SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
09/01/202402:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
09/01/202402:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
09/01/202402:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
09/01/202402:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
09/01/202402:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
09/01/202402:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SWTXSpringWorks Therapeutics Inc
08/01/202411:30GlobeNewswire Inc.SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SWTXSpringWorks Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SWTX

Your Recent History

LSE
POS
Plexus
LSE
TERN
Tern
LSE
SCLP
Scancell
LSE
VAL
Valirx
LSE
VAST
Vast Resources
LSE
BP.
Bp
LSE
PHE
Powerhouse Energy
LSE
YU.
Yu
LSE
TEK
Tekcapital
LSE
GKP
Gulf Keystone Petroleum
LSE
MIN
Minoan
LSE
SYME
Supply@me Capital
LSE
SOLG
Solgold
LSE
CHLL
Chill Brands
LSE
KEFI
Kefi Gold And Copper
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved